Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 192

The DOI matches its Crossref record.

New WHO Classification of Endometrial Hyperplasias

Open access
Emons, G., Beckmann, M., Schmidt, D., Mallmann, P., for the Uterus commission of the Gynecological Oncology Working Group (AGO) · 2015 · Geburtshilfe und Frauenheilkunde

Abstract

Endometrioid endometrial carcinoma, the most common form of endometrial cancer, usually develops out of a typical sequence of endometrial hyperplasias. The underlying cause of these hyperplasias is a relative predominance of estrogen combined with insufficient progesterone levels. Typical causes include corpus luteum insufficiency/anovulatory cycles (premenopause), polycystic ovary syndrome and obesity with metabolic syndrome (aromatase conversion of ovarian androgens in adipose tissue), inappropriate hormone therapy post menopause (insufficient dosage of gestagens) or an estrogen or androgen-producing tumor [ 1 ]. Even in patients with Lynch syndrome (formerly known as HNPCC), tumorigenesis of hereditary endometrioid carcinoma usually follows the usual progression with development of the respective hyperplasias [ 1 ]. Up to now, the correct clinical evaluation of endometrial hyperplasias was made more difficult by the different classification systems still in use: in Germany hyperplasias are sometimes still differentiated according to the classification “glandular-cystic hyperplasia” and “adenomatous hyperplasia grade I to III”. In 1994, the WHO classified endometrial hyperplasias into 4 categories: simple hyperplasia without atypia, complex hyperplasia without atypia, simple atypical hyperplasia, complex atypical hyperplasia [ 1 ], [ 2 ]. While categories 1, 2 and 4 were generally accepted, pathologists continued to debate the existence of group 3-type hyperplasias. Hyperplasias without atypia (categories 1 and 2) are considered benign pathologies which will regress with conservative treatment (oral gestagens, gestagen IUD, elimination of the cause of anovulation/corpus luteum insufficiency) [ 1 ]. A large percentage (up to 60 %) [ 3 ] of atypical endometrial hyperplasias (categories 3 and 4) are found to be coexistent with invasive endometrial carcinoma or develop into invasive endometrial carcinoma within the space of just a few years [ 1 ], [ 2 ], [ 4 ]. Hysterectomy (total hysterectomy, not supracervical hysterectomy!) is therefore the treatment of choice for atypical endometrial hyperplasia [ 4 ] or – in selected patients, i.e. younger patients wanting to have children – high-dose gestagen therapy with appropriate close histological monitoring [ 1 ], [ 4 ]. The WHO classification of 1994 and even more so the parallel use of the older classification system led to confusion among clinicians. The consequence of this was inadequate diagnosis, with hysterectomies performed for hyperplasias without atypia or gestagens administered in HRT dosages for atypical hyperplasia. Pathologists also experienced difficulties with categorization. This was made even more difficult by the development and parallel use of a further classification system: benign hyperplasia and endometrial intraepithelial neoplasia (EIN) [ 2 ]. In its latest classification [ 5 ] published in 2014, the WHO has clarified the matter: it now only differentiates between 2 categories of endometrial hyperplasia: hyperplasia without atypia atypical hyperplasia/endometrioid intraepithelial neoplasia ([ Table 1 ]). Table 1 New WHO classification of endometrial hyperplasias [ 5 ]. New term Synonyms Genetic changes Coexistent invasive endometrial carcinoma Progression to invasive carcinoma Hyperplasia without atypia Benign endometrial hyperplasia; simple non-atypical endometrial hyperplasia; complex non-atypical endometrial hyperplasia; simple endometrial hyperplasia without atypia; complex endometrial hyperplasia without atypia Low level of somatic mutations in scattered glands with morphology on HE staining showing no changes < 1 % RR: 1.01–1.03 Atypical hyperplasia/endometrioid intraepithelial neoplasia Complex atypical endometrial hyperplasia; simple atypical endometrial hyperplasia; endometrial intraepithelial neoplasia (EIN) Many of the genetic changes typical for endometrioid endometrial cancer are present, including: micro satellite instability; PAX2 inactivation; mutation of PTEN, KRAS and CTNNB1 (β-catenin) 25–33 % [ 5 ] 59 % [ 3 ] RR: 14–45 This reduction to 2 categories was not only due to the need to do away with the confusing multitude of terms currently in use. Rather, it reflects a new understanding of molecular genetic changes. Hyperplasias without atypia exhibit no relevant genetic changes. They are benign changes and will regress again after the endocrine milieu (physiological gestagen levels) has normalized. In a few cases (1–3 %), progression to invasive disease may occur if the endocrine disorder (long-term estrogen dominance or relative or absolute gestagen deficiency) persists over the long term. Atypical endometrial hyperplasias exhibit many of the mutations typical for invasive endometrioid endometrial cancer [ 7 ]. In up to 60 % of cases, patients have coexisting invasive cancer or are at extremely high risk of developing invasive cancer ([ Table 1 ]). The implications for treatment are obvious: hyperplasias without atypia sh

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0034-1396256

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 192

Metadata

Authors
Emons, G., Beckmann, M., Schmidt, D., Mallmann, P., & for the Uterus commission of the Gynecological Oncology Working Group (AGO)
Venue
Geburtshilfe und Frauenheilkunde
Published
2015-03-16
Volume
75
Issue
02
Pages
135-136
ISSN
  • 0016-5751 (ISSN-L)
  • 1438-8804
OpenAlex
W2327800659
Cited by
192
References
0
FWCI
9.08
Type
journal article
Language
de
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New WHO Classification of Endometrial Hyperplasias. https://app.cochat.ai/papers/10.1055/s-0034-1396256
The paper
Emons, G., Beckmann, M., Schmidt, D., Mallmann, P., & for the Uterus commission of the Gynecological Oncology Working Group (AGO). (2015). New WHO Classification of Endometrial Hyperplasias. Geburtshilfe und Frauenheilkunde. https://doi.org/10.1055/s-0034-1396256

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.